Commentary: IMRT for Head and Neck Cancer: Many Chapters Left to Write

Abstract

Disclosure of potential conflicts of interest is found at the end of this article.

Salvage Treatment Improved Survival of Patients With Relapsed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

“…The radiation-induced toxicities were endurable. Recent studies have demonstrated that target volume coverage and critical organ protection were significantly improved with intensity-modulated radiotherapy (IMRT) compared with 3D-CRT in head-and-neck malignant tumor (13,14). It is reasonable for us to hypothesize that the higher dose could be given to involved regions and that OS might be improved by IMRT.…”

IMRT dose fractionation for head and neck cancer: Variation in current approaches will make standardisation difficult

“…When concurrent chemoradiation is used, there is further variation over the choice of optimum fractionation schedule. IMRT, with its potential for Simultaneous Integrated Boost (SIB), further adds to this uncertainty [1] such that there is an increasing lack of uniformity of practice with no single 'standard of care'.…”